ArticleOncogene2022

GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis.

Yujie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.